Product Information
BUPRENORPHINE 2 MG TABLET SL is a generic product labeled by Actavis Pharma, Inc., priced at $0.2648 per EA under NDC 00228315603. Its NADAC has been published 589 times since May 13, 2015.
FDA first approved this application on Feb 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228315603
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090819FDA Approved
2/19/2015
TE Code
AB
On Market Since
2/19/2015
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 2 MG TABLET SL has been published 589 times since May 13, 2015, and over the history we have for it it has declined 81.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2648 per EA |
|---|---|
| All-time high | $1.4708 (Aug 12, 2015) |
| All-time low | $0.2629 (Jun 17, 2026) |
| 52-week high | $0.3179 |
| 52-week low | $0.2629 |
| Median price | $0.5319 |
| Average price | $0.6535 |
| Largest weekly change | +47.3% (Dec 21, 2016) |
| Weeks tracked | 589 |
| Tracking since | May 13, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 2 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 2 MG TABLET SL, manufactured by Actavis Pharma, Inc., is $0.2648 per EA (NDC 00228315603), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 2 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 2 MG TABLET SL has declined 81.1%. It has been tracked across 589 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 2 MG TABLET SL?
Since May 13, 2015, the NADAC for BUPRENORPHINE 2 MG TABLET SL has ranged from a low of $0.2629 (Jun 17, 2026) to a high of $1.4708 (Aug 12, 2015), with a median of $0.5319 per EA.
Are there cheaper alternatives to BUPRENORPHINE 2 MG TABLET SL?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 2 MG TABLET SL in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 2 MG TABLET SL?
BUPRENORPHINE 2 MG TABLET SL (NDC 00228315603) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.